[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1252350A1 - Mrka多肽、抗體及其用途 - Google Patents

Mrka多肽、抗體及其用途

Info

Publication number
HK1252350A1
HK1252350A1 HK18111635.8A HK18111635A HK1252350A1 HK 1252350 A1 HK1252350 A1 HK 1252350A1 HK 18111635 A HK18111635 A HK 18111635A HK 1252350 A1 HK1252350 A1 HK 1252350A1
Authority
HK
Hong Kong
Prior art keywords
antibodies
mrka polypeptides
mrka
polypeptides
Prior art date
Application number
HK18111635.8A
Other languages
English (en)
Inventor
Qun Wang
Saravanan RAJAN
Chew-Shun Chang
Thompson Jenny Heidbrink
Hung-Yu Lin
Charles Kendall Stover
Meghan Pennini
William Dall'acqua
Partha S Chowdhury
Xiaodong Xiao
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Publication of HK1252350A1 publication Critical patent/HK1252350A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
HK18111635.8A 2015-08-24 2018-09-11 Mrka多肽、抗體及其用途 HK1252350A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562208975P 2015-08-24 2015-08-24
US201562238828P 2015-10-08 2015-10-08

Publications (1)

Publication Number Publication Date
HK1252350A1 true HK1252350A1 (zh) 2019-05-24

Family

ID=58100831

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18111635.8A HK1252350A1 (zh) 2015-08-24 2018-09-11 Mrka多肽、抗體及其用途

Country Status (16)

Country Link
US (2) US20170073397A1 (zh)
EP (1) EP3341004A4 (zh)
JP (1) JP2018527924A (zh)
KR (1) KR20180042300A (zh)
CN (1) CN107921086A (zh)
AU (1) AU2016313653A1 (zh)
BR (1) BR112018003252A2 (zh)
CA (1) CA2995387A1 (zh)
CL (1) CL2018000357A1 (zh)
CO (1) CO2018001985A2 (zh)
HK (1) HK1252350A1 (zh)
IL (1) IL257434A (zh)
MX (1) MX2018001964A (zh)
RU (1) RU2018107056A (zh)
TW (1) TW201718626A (zh)
WO (1) WO2017035154A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3496748A4 (en) * 2016-08-05 2020-01-15 Medimmune, LLC ANTI-O2 ANTIBODIES AND USES THEREOF
JP7160484B2 (ja) 2016-10-19 2022-10-25 メディミューン，エルエルシー 抗ｏ１抗体およびその使用
CA3067587A1 (en) 2017-06-23 2018-12-27 Nosocomial Vaccine Corporation Immunogenic compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020062010A1 (en) * 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
US7041465B1 (en) * 1999-08-11 2006-05-09 Washington University Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof
AU7470300A (en) * 1999-08-11 2001-03-05 Washington University Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof
WO2005034733A2 (en) * 2003-10-08 2005-04-21 North Shore-Long Island Jewish Research Institute Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
EA018030B1 (ru) * 2006-06-06 2013-05-30 Круселл Холланд Б.В. Связывающие молекулы человека, имеющие убивающую активность против стафилококков, и их применения
GB0615662D0 (en) * 2006-08-07 2006-09-13 Affitech As Antibody
JP2010532657A (ja) * 2007-05-02 2010-10-14 インターセル アーゲー クレブシエラ属の抗原
GB0915403D0 (en) * 2009-09-04 2009-10-07 London School Hygiene & Tropical Medicine Protein glycosylation
EP2533807A2 (en) * 2010-02-12 2012-12-19 University Of Rochester Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies
US9567393B2 (en) * 2010-10-26 2017-02-14 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University Antibody based reagent that specifically recognizes toxic oligomeric form of beta-amyloid
EP2776065B1 (en) * 2011-11-07 2020-08-05 MedImmune Limited Combination therapies using anti- pseudomonas psl and pcrv binding molecules

Also Published As

Publication number Publication date
TW201718626A (zh) 2017-06-01
AU2016313653A1 (en) 2018-04-12
US20170073397A1 (en) 2017-03-16
CA2995387A1 (en) 2017-03-02
US20190062411A1 (en) 2019-02-28
EP3341004A4 (en) 2019-05-15
EP3341004A1 (en) 2018-07-04
JP2018527924A (ja) 2018-09-27
BR112018003252A2 (pt) 2018-09-25
IL257434A (en) 2018-04-30
KR20180042300A (ko) 2018-04-25
CN107921086A (zh) 2018-04-17
MX2018001964A (es) 2018-06-19
RU2018107056A (ru) 2019-09-26
WO2017035154A1 (en) 2017-03-02
CL2018000357A1 (es) 2018-07-20
CO2018001985A2 (es) 2018-11-22

Similar Documents

Publication Publication Date Title
IL283321A (en) Antibodies against muc16 and their uses
IL285375A (en) Antibodies that bind to il-8 and their uses
IL264654B1 (en) Anti-tigit antibodies, anti-pvrig antibodies and their combinations
HK1254861A1 (zh) 抗lag3抗體及其用途
HK1250238A1 (zh) 抗angptl8抗體及其用途
IL262095A (en) Anti-pacap antibodies and their use
HK1256381A1 (zh) 抗pacap抗體及其用途
IL265689A (en) Antibodies against il-33 and their use
GB201503387D0 (en) Anti-carbapenem antibodies and uses thereof
IL252430A0 (en) Antibodies, uses and methods
PL3292154T3 (pl) Przeciwciała przeciwko ludzkiemu HER3 i ich zastosowania
IL266049A (en) Antibodies against o1 and their uses
IL264417A (en) Anti-o2 antibodies and their uses
HK1254240A1 (zh) 抗羥腐胺賴氨酸抗體及其用途
IL266082A (en) Anti-chikv antibodies and their use
GB201405784D0 (en) Novel methods, polypeptides and uses thereof
HK1252350A1 (zh) Mrka多肽、抗體及其用途
GB201519105D0 (en) Antibody polypeptides and uses thereof
GB201517550D0 (en) Antibody polypeptides and uses thereof
GB201618515D0 (en) Combinations comprising antibodies, uses and methods
GB201401973D0 (en) Antibody polypeptides and uses thereof